FIELD: chemistry.
SUBSTANCE: invention describes a compound of formula I or its pharmaceutically acceptable salt 
, where R, R9, Z, X, Q and Y are defined in the formula of invention. The compounds are chemokine receptor 2 and chemokine receptor 5 antagonists and can be used as a medicinal agent for preventing, relieving or treating autoimmune or inflammatory diseases or conditions.
EFFECT: obtaining a formula (I) compound, a pharmaceutical composition based on the formula (I) compound, use of the compound in paragraph 1 to prepare a medicinal agent for treating an autoimmune or inflammatory disease or condition, as well as use of the compound in paragraph 1 to prepare a medicinal agent for treating HIV infection or AIDS.
11 cl, 181 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINEAMIDES AND THEIR DERIVATIVES, METHODS OF TREATMENT OF PATIENTS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2143424C1 |
| NOVEL HETEROCYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2018 |
|
RU2733384C1 |
| NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
| NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
| NAPHTHALENE DERIVATIVES SUITABLE FOR USE AS LIGANDS OF HISTAMINE 3 RECEPTORS | 2005 |
|
RU2387638C2 |
| C-6 MODIFIED INDAZOLYL PYRROLOTRIAZINES | 2003 |
|
RU2356903C2 |
| SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
| NOVEL AMIDE DERIVATIVE FOR INHIBITING GROWTH OF CANCER CELLS | 2008 |
|
RU2434010C2 |
| SUBSTITUTED N-(INDOLE-2-CARBONYL)-BETA-ALANYLAMIDES AND THEIR DERIVATIVES, METHOD OF TREATING GLYCOGENPHOSPHORYLAZO-DEPENDENT DISEASES, METHOD FOR PREVENTING ISCHEMIC MYOCARDIUM DAMAGES, AND PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159613C2 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2009 |
|
RU2503676C2 |
